Ligand validation:5EX3

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 5EX3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5EX3_SAH_A_504	88%	29%	0.095	0.97	1.23	1.6	3	4	0	0	100%	1
5HQ8_SAH_A_507	98%	28%	0.053	0.976	1.49	1.4	3	3	0	0	100%	1
6O9O_SAH_A_509	96%	34%	0.068	0.976	1.15	1.45	2	2	0	0	100%	1
6P6G_SAH_A_509	96%	34%	0.068	0.976	1.15	1.45	2	2	0	0	100%	1
3OXF_SAH_A_437	70%	36%	0.144	0.963	1.09	1.4	1	5	0	0	100%	1
5EX0_SAH_A_504	69%	29%	0.142	0.957	1.22	1.61	3	5	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.